Blueberry Therapeutics have unique nanopolymer drug delivery technology... ...which opens up huge opportunities to rapidly develop new medicines... ...and helps us find ways to treat dermatological disorders.
The Blueberry team are delighted to be moving into a larger, more spacious office area on the Alderley Park [...]
Susan Yau2020-09-23T12:43:59+00:00September 23rd, 2020|
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.